Markets:

Overview

News

Currencies

International

Treasuries

Fidelity MSCI Health Care Index ETF (NY:FHLC)

77.69 +0.26 (+0.34%)

Streaming Delayed Price Updated: 1:47 PM EDT, Jul 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fidelity MSCI Health Care Index ETF

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best? ↗

July 05, 2026

One offers broad stability with lower costs and higher income, while the other chases biotech growth with 89.3% annual returns but steeper volatility.

Via The Motley Fool

Topics ETFs

FHLC vs. BBH: Which Healthcare ETF Is the Better Buy? ↗

July 04, 2026

Compare fees, diversification, and risk between these two leading healthcare ETFs.

Via The Motley Fool

Topics ETFs

Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value? ↗

June 26, 2026

Compare global reach to domestic focus as these two funds reveal key differences in cost, risk, and portfolio makeup for healthcare investors.

Via The Motley Fool

Topics ETFs

FDA To Ease Review Process For Life-Saving Gene-Editing Therapies: Report ↗

October 31, 2025

Via Stocktwits

BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗

September 10, 2025

Via Stocktwits

BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗

August 27, 2025

Via Stocktwits

FHLC vs. IYH: Which Healthcare ETF Is the Better Buy in 2026? ↗

June 16, 2026

Portfolio size and stock selection set these healthcare ETFs apart and help shape their risk and return profiles.

Via The Motley Fool

Topics ETFs

Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns. ↗

June 02, 2026

Expense ratios, asset size, and portfolio strategy set these two healthcare ETFs apart, yet their risk and dividend profiles tell a different story.

Via The Motley Fool

Topics ETFs

Better Health Care ETF: Fidelity's FHLC vs. State Street's XLV ↗

May 24, 2026

Expense ratios match, but portfolio breadth, yield, and stock concentration set these two healthcare ETFs apart for investors seeking sector exposure.

Via The Motley Fool

Topics ETFs

Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations ↗

March 06, 2025

A federal court blocked NIH's policy capping indirect cost rates on research grants, ruling it unlawful. The decision safeguards billions in funding and ongoing clinical trials.

Via Benzinga

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

ETFs In Focus Post UnitedHealth's Mixed Q4 Results ↗

January 18, 2025

UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the...

Via Talk Markets

Topics ETFs Stocks / Equities

What Lies In Store For Healthcare ETFs In Q3 Earnings? ↗

October 27, 2024

The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited.

Via Talk Markets

Topics ETFs

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups ↗

October 05, 2023

A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests to detect diseases sooner and personalize treatments.

Via Benzinga

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗

July 07, 2023

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...

Via Benzinga

Worried About the Markets? Buy and Hold These 2 Cheap ETFs. ↗

July 06, 2023

These funds have generated returns north of 60% over the past five years and make for relatively safe investments.

Via The Motley Fool

Healthcare ETFs in Focus as Q2 Earnings Unfold ↗

July 22, 2021

Let’s dig deeper into the earnings picture of the companies which will drive the performance of healthcare funds in the coming days.

Via Talk Markets

Healthcare ETFs on Radar As Q1 Earnings Unfold ↗

April 28, 2021

The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.